NIH-funded research R01 grant

Understanding how to make pelvic floor physical therapy easier to do for women with high tone pelvic floor dysfunction

Official title: Phenotypic differences in response to treatment for high tone pelvic floor dysfunction

Funded at University of Michigan at Ann Arbor · NIH-11273487 · Data updated 2026-11-12

This NIH grant tests whether adding a pain-relief medicine called cyclobenzaprine to pelvic floor physical therapy helps people with high tone pelvic floor dysfunction stick with treatment and feel better.

More Pelvic Floor Dysfunction research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 15, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$670,800
NIH project number1R01HD120523-01
Project IDNIH-11273487 on NIH RePORTER

Who could benefit from this research

Could help

Adults with high tone pelvic floor dysfunction who are candidates for pelvic floor physical therapy and may have pain limiting therapy participation.

Less likely to help

Patients who do not respond to centrally-acting medications or have contraindications to cyclobenzaprine may see limited benefit.

What this research studies

For people with chronic pelvic pain caused by high tone pelvic floor dysfunction, the project explores whether combining pelvic floor physical therapy with a centrally acting muscle relaxant can improve adherence and outcomes. The study builds on evidence that centralized pain mechanisms can reduce response to peripheral therapies and that multi-pronged treatment may yield better results. Researchers will examine pain, participation in therapy, and symptom changes over time to see if the combination works better than standard therapy alone. The work is conducted at the University of Michigan with a patient-centered approach to reduce barriers to completing therapy and achieving meaningful relief.

Why it matters

Potential benefit: If successful, patients may experience better pain control and higher participation in PFPT, leading to improved functional outcomes.

How similar studies have gone: Previous studies suggest that adjuvant strategies can enhance efficacy in related conditions, though this exact combination is being tested.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Till, Sara R — University of Michigan at Ann Arbor
  • Study coordinator: Till, Sara R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.